Lithuania
Sentante, established in 2017 and headquartered in Lithuania, is pioneering the realm of robotic-assisted medical interventions with its slogan: "Sentante - the first fully-robotic teleoperated system for endovascular interventions".
The core innovation of Sentante lies in its smart, sensory network, which enables remote execution of endovascular procedures. The system showcases a novel teleoperated robot that safeguards physicians from harmful X-ray exposure and introduces potential for tele-surgery. Its compatibility with conventional guidewires and catheters allows seamless operation using familiar tools. Additionally, the patented sensing technology offers real-time haptic feedback, simulating an in-person tactile experience.
Following a recent financial boost, Sentante secured a €6.00M Seed investment on December 1, 2023, from Practica Capital and the EIC Fund. This investment positions Sentante for accelerated growth in the advanced medical robotics market.
